Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 2
2005 3
2006 1
2007 3
2008 3
2010 3
2011 5
2012 2
2013 4
2014 6
2016 4
2017 6
2018 5
2019 8
2020 12
2021 6
2022 7
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. Among authors: coyle pk. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Lyme disease.
Coyle PK. Coyle PK. Curr Neurol Neurosci Rep. 2002 Nov;2(6):479-87. doi: 10.1007/s11910-002-0033-2. Curr Neurol Neurosci Rep. 2002. PMID: 12359100 Review.
Central Nervous System Vasculitis due to Infection.
Younger DS, Coyle PK. Younger DS, et al. Among authors: coyle pk. Neurol Clin. 2019 May;37(2):441-463. doi: 10.1016/j.ncl.2019.01.002. Epub 2019 Mar 16. Neurol Clin. 2019. PMID: 30952418 Review.
Gender issues.
Coyle PK. Coyle PK. Neurol Clin. 2005 Feb;23(1):39-60, v-vi. doi: 10.1016/j.ncl.2004.10.003. Neurol Clin. 2005. PMID: 15661087 Review. No abstract available.
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators. Fox RJ, et al. Among authors: coyle pk. N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583. N Engl J Med. 2018. PMID: 30157388 Free PMC article. Clinical Trial.
Gender issues in multiple sclerosis: an update.
Jobin C, Larochelle C, Parpal H, Coyle PK, Duquette P. Jobin C, et al. Among authors: coyle pk. Womens Health (Lond). 2010 Nov;6(6):797-820. doi: 10.2217/whe.10.69. Womens Health (Lond). 2010. PMID: 21118039 Free article. Review.
84 results